FMP
Sep 14, 2021 6:20 PM - Davit Kirakosyan
aTyr Pharma, Inc. (NASDAQ:LIFE) shares were trading at the highest level since 2018, hitting the daily high of $12.97 today morning.
The reason is that the company presented top-line data from its Phase 1b/2a double-blind, placebo-controlled clinical trial of ATYR1923 in 37 patients with pulmonary sarcoidosis. The data surpassed the expectations, demonstrating a dose dependent improvement in such diverse efficacy measurements as steroid sparing (reduction), Forced Vital Capacity (FVC), clinical/QOL measurements like dyspnea, cough, etc., and inflammatory biomarker reductions; all this with little change in the safety profile of the drug.
Sep 11, 2023 - Rajnish Katharotiya
During this post we are going to perform an industry analysis with Python. We will build, analyse and compare all stocks operating within an industry. To do so, we will pick an industry and get all important financial metrics for companies operating in that industry. Then, we will use a couple of fi...
Sep 11, 2023 - Rajnish Katharotiya
Price to Earnings is one of the key metrics use to value companies using multiples. The P/E ratio and other multiples are relative valuation metrics and they cannot be looked at in isolation. One of the problems with the P/E metric is the fact that if we are in the peak of a business cycle, earni...
Sep 11, 2023 - Rajnish Katharotiya
Would you like to know how your portfolio is performing and how much risk you are taking? In this post, you will learn how to measure portfolio risk and calculate portfolio returns using Python. We will see step by step how to calculate the risk and returns of a portfolio containing four stocks Appl...